Cargando...
Immunotherapy for hematological malignancies
Tumor immune tolerance remains a major barrier for effective anti-cancer therapy. A growing number of pathways whereby solid tumors escape immune surveillance have been characterized (1). This progress led us to revisit the “hallmarks of cancer” and brought forward many promising immunotherapies. Ev...
Guardado en:
| Publicado en: | J Life Sci (Westlake Village) |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709701/ https://ncbi.nlm.nih.gov/pubmed/31453573 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|